Cannasouth (NZSE:CBD) Equity-to-Asset : 0.87 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Cannasouth Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cannasouth's Total Stockholders Equity for the quarter that ended in Dec. 2023 was NZ$48.35 Mil. Cannasouth's Total Assets for the quarter that ended in Dec. 2023 was NZ$55.45 Mil. Therefore, Cannasouth's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.87.

The historical rank and industry rank for Cannasouth's Equity-to-Asset or its related term are showing as below:

NZSE:CBD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.66 Med: 0.87 Max: 0.97
Current: 0.87

During the past 5 years, the highest Equity to Asset Ratio of Cannasouth was 0.97. The lowest was 0.66. And the median was 0.87.

NZSE:CBD's Equity-to-Asset is ranked better than
90.25% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs NZSE:CBD: 0.87

Cannasouth Equity-to-Asset Historical Data

The historical data trend for Cannasouth's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannasouth Equity-to-Asset Chart

Cannasouth Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Equity-to-Asset

0.97

0.73

0.66

0.87

Cannasouth Semi-Annual Data
	Jun19	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial				0.73	0.66	0.66	0.90	0.87

Competitive Comparison of Cannasouth's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Cannasouth's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannasouth's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannasouth's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cannasouth's Equity-to-Asset falls into.

Cannasouth Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cannasouth's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	48.345	/	55.454
	=	0.87

Cannasouth's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	48.345	/	55.454
	=	0.87

Cannasouth (NZSE:CBD) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Cannasouth Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cannasouth's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannasouth (NZSE:CBD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannasouth Ltd (NZSE:CBD) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Level 2 / 2 Melody Lane, CRV Building, Waikato Innovation Park, Hamilton East, Hamilton, NZL, 3216

Website

https://www.cannasouth.co.nz

Cannasouth Ltd is a New Zealand based company involved in the medicinal cannabis sector. Its focus is to research the benefits of medicinal cannabis and to develop a range of medicinal cannabis-related products for distribution in New Zealand and globally. The company operates in single segment: the biopharmaceutics market i.e., the production and supply (including research and development) of biopharmaceuticals, specializing in cannabinoid medicines; with the area of operation being New Zealand.

Cannasouth (NZSE:CBD) Headlines

No Headlines